Cystitis News and Research RSS Feed - Cystitis News and Research

Cystitis is inflammation of the urinary bladder. The condition more often affects women, but can affect either sex and all age groups.
Urinary nerve growth factor shows diagnostic value

Urinary nerve growth factor shows diagnostic value

Urinary nerve growth factor could be a useful biomarker for the diagnosis of overactive bladder and a predictive biomarker to help guide treatment, Chinese researchers believe. [More]
Loyola announces opening of new acupuncture clinic for patients with pelvic health disorders

Loyola announces opening of new acupuncture clinic for patients with pelvic health disorders

Loyola University Health System will open an acupuncture clinic for men and women with pelvic health disorders this fall. The clinic will use acupuncture to treat patients with common conditions such as pelvic pain, nausea from pelvic surgery, interstitial cystitis, painful bladder syndrome, postoperative pain, prostatitis and overactive bladder. [More]
Scientists aim to understand and treat painful bladder condition

Scientists aim to understand and treat painful bladder condition

Taking advantage of technology that can analyze tissue samples and measure the activity of thousands of genes at once, scientists at Wake Forest Baptist Medical Center are on a mission to better understand and treat interstitial cystitis (IC), a painful and difficult-to-diagnose bladder condition. [More]
OAB and interstitial cystitis/bladder pain syndrome show considerable overlap

OAB and interstitial cystitis/bladder pain syndrome show considerable overlap

There is considerable overlap between symptoms in patients with interstitial cystitis/bladder pain syndrome and those with overactive bladder, US researchers have shown. [More]

Squatty Potty toilet stool improves severity of constipation symptoms

When used as a treatment, the original Squatty Potty (www.squattypotty.com) toilet stool significantly improves the severity of constipation symptoms within one month of use among 84 percent of the participants of a recently released scientific study. [More]
NAFC honors Dr. Alan J. Wein with Rodney Appell Continence Care Champion award

NAFC honors Dr. Alan J. Wein with Rodney Appell Continence Care Champion award

The National Association For Continence presented Alan J. Wein, MD, FACS, PhD(hon) with its Rodney Appell Continence Care Champion award at the Society of Urodynamics, Female Pelvic Medicine, & Urogenital Reconstruction's 2014 Annual Meeting in Orlando, FL on February 28, 2014. [More]
Scientists progress towards understanding how some bacterial cells escape being killed by antibiotics

Scientists progress towards understanding how some bacterial cells escape being killed by antibiotics

Scientists have made an important advance in understanding how a subset of bacterial cells escape being killed by many antibiotics. [More]
Sacral neuromodulation stands test of time in LUTD

Sacral neuromodulation stands test of time in LUTD

Follow-up of patients at a Belgian institution reveals that sacral neuromodulation is effective for the treatment of lower urinary tract dysfunction over the long term, but often requires reintervention. [More]
Dietary change should be considered in chronic prostatitis

Dietary change should be considered in chronic prostatitis

Researchers from the USA say that physicians should consider dietary changes for patients with chronic prostatitis/chronic pelvic pain syndrome to improve symptoms. [More]
Women are more likely to suffer urinary tract infections, but men are more prone to be hospitalized

Women are more likely to suffer urinary tract infections, but men are more prone to be hospitalized

While women are far more likely to suffer urinary tract infections, men are more prone to be hospitalized for treatment, according to a study by Henry Ford Hospital urologists. [More]
Amgen presents data from several romosozumab and Prolia at ASBMR 2013 Annual Meeting

Amgen presents data from several romosozumab and Prolia at ASBMR 2013 Annual Meeting

Amgen today announced that it will present data from several romosozumab and Prolia® (denosumab) studies at the American Society for Bone and Mineral Research (ASBMR) 2013 Annual Meeting in Baltimore from Oct. 4-7, 2013. [More]
Hyperthyroidism sounds urinary problem alarm

Hyperthyroidism sounds urinary problem alarm

Physicians should be alert to urinary problems in women with hyperthyroidism, say researchers who found an association between the endocrine disorder and bladder pain syndrome/interstitial cystitis. [More]
"Millions Suffer, Few Understand" encourages patients to talk openly about IC/BPS

"Millions Suffer, Few Understand" encourages patients to talk openly about IC/BPS

This September, patients around the world will unite to share their personal stories and struggles with interstitial cystitis / bladder pain syndrome (IC/BPS). The 2013 theme, "Millions Suffer, Few Understand" encourages patients and providers to talk openly about this common yet often misunderstood pelvic pain condition. [More]
Researchers develop reliable way to use finger-stick blood sample to detect fibromyalgia syndrome

Researchers develop reliable way to use finger-stick blood sample to detect fibromyalgia syndrome

Researchers have developed a reliable way to use a finger-stick blood sample to detect fibromyalgia syndrome, a complicated pain disorder that often is difficult to diagnose. [More]
FDA approves Gilotrif for patients with late stage non-small cell lung cancer

FDA approves Gilotrif for patients with late stage non-small cell lung cancer

Companion test also approved to identify appropriate patients The U.S. Food and Drug Administration today approved Gilotrif (afatinib) for patients with late stage (metastatic) non-small cell lung cancer (NSCLC) whose tumors express specific types of epidermal growth factor receptor (EGFR) gene mutations, as detected by an FDA-approved test. Lung cancer is the leading cause of cancer-related death among men and women. [More]
Research findings provide new hope for people suffering from dry eye disease

Research findings provide new hope for people suffering from dry eye disease

Natural lubricants play an important role in health, including a well-known effect to help prevent osteoarthritis in knee and ankle joints. However, much is still unknown about their role and function in other areas of the body. [More]
First patient dosed in second Phase 2 study with LiRIS for treatment of Interstitial Cystitis

First patient dosed in second Phase 2 study with LiRIS for treatment of Interstitial Cystitis

TARIS Biomedical, a specialty pharmaceutical company developing innovative, targeted therapies to treat bladder diseases with high unmet medical need, announced today that it has dosed the first patient in its second Phase 2 clinical study with LiRIS, its novel product candidate, in patients with Interstitial Cystitis. [More]
New therapeutic approach for bladder pain syndrome

New therapeutic approach for bladder pain syndrome

Severe chronic pain associated with conditions such as bladder pain syndrome/interstitial cystitis often require the use of opioid medication, with the risk of dependency and serious adverse reactions. [More]
Canine lymphoma treatment adds up to cystitis

Canine lymphoma treatment adds up to cystitis

High cumulative doses of the alkylator cyclophosphamide could be to blame for the development of sterile hemorrhagic cystitis in dogs being treated for lymphoma, indicate the results of a US study. [More]
Amgen receives FDA approval for Prolia to treat bone loss in men with osteoporosis

Amgen receives FDA approval for Prolia to treat bone loss in men with osteoporosis

Amgen today announced the U.S. Food and Drug Administration (FDA) approved a new indication for Prolia (denosumab) as a treatment to increase bone mass in men with osteoporosis at high risk for fracture. [More]